Evidence map›Paper›PMID 40832647›Full record

ArticleBMJ public health2025

Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies.

Antonio Ancidoni, Simone Salemme, Domitilla Marconi, Guido Bellomo, Sara Maria Pani, Nicoletta Locuratolo, Eleonora Lacorte, Flavia Lucia Lombardo, Ilaria Bacigalupo, Elisa Fabrizi and 22 more

Abstract read
In one paragraph

Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Antonio Ancidoni *National Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.ORCID https://orcid.org/0000-0002-3949-3127
Simone Salemme *Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID https://orcid.org/0000-0002-9260-9993
Domitilla MarconiPost Graduate School of Public Health, University of Siena, Siena, Italy.
Guido BellomoNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Sara Maria PaniDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Sardegna, Italy.
Nicoletta LocuratoloNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Eleonora LacorteNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Flavia Lucia LombardoNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Ilaria BacigalupoNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Elisa FabriziNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.ORCID https://orcid.org/0000-0001-5888-6885
Marco CanevelliNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Francesco SciancaleporeNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Patrizia LorenziniNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Ilaria PalazzesiNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Alice PaggettiNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Francesco Della GattaDepartment of Neuroscience, Mental Health and Sense Organs (NESMOS), Faculty of Medicine and Psychology, Università degli Studi di Roma La Sapienza, Rome, Lazio, Italy.
Paola PiscopoDepartment of Neuroscience, Istituto Superiore di Sanita, Roma, Italy.
Emanuela SalviNational Centre for Drug Research and Evaluation, Istituto Superiore di Sanita, Roma, Italy.
Francesca ZambriNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Annachiara Di NolfiDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Roma, Lazio, Italy.
Vittorio PalermoNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
Paolo SciattellaEconomic Evaluation and HTA (EEHTA-CEIS), DEF Department, Faculty of Economics, University of Rome Tor Vergata, Roma, Lazio, Italy.
Chiara BiniEconomic Evaluation and HTA (EEHTA-CEIS), DEF Department, Faculty of Economics, University of Rome Tor Vergata, Roma, Lazio, Italy.
Francesco Saverio MenniniEconomic Evaluation and HTA (EEHTA-CEIS), DEF Department, Faculty of Economics, University of Rome Tor Vergata, Roma, Lazio, Italy.
Caterina Bianca Neve Aurora BianchiGeneral directorate for prevention, Ministero della Salute, Roma, Lazio, Italy.
Fiammetta LandoniGeneral directorate for prevention, Ministero della Salute, Roma, Lazio, Italy.
Maria Assunta GianniniGeneral directorate for prevention, Ministero della Salute, Roma, Lazio, Italy.
Teresa Di FiandraScientific consultant, Istituto Superiore di Sanita, Roma, Italy.
Nicola VanacoreNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanita, Rome, Italy.
National Committee on Dementia of the National Dementia Plan
FONDEM Study Group
National Guideline Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Dementia is a growing global public health priority, with the WHO Global Action Plan (GAP) calling for coordinated efforts worldwide. Italy, one of the oldest nations globally, faces a significant challenge with approximately 2 million individuals living with dementia or mild cognitive impairment. In response, the Italian Fund for Alzheimer's and other Dementias (IFAD) was established in 2020 to align national efforts with the WHO GAP's objectives. This study analyses IFAD activities from 2021 to 2023, offering insights into Italy's public health response to dementia and its relevance to global strategies. Methods: We conducted a structured, iterative review of all activities coordinated by the Italian Dementia Observatory (OssDem-Istituto Superiore di Sanità (ISS)) within IFAD 2021-2023. Global, regional and national documents on dementia prevention, care and support were retrieved from official websites, institutional repositories and targeted web searches using the keywords 'dementia', 'brain health' and 'ageing'. Two reviewers independently screened and extracted data with a predefined matrix mapped to the seven WHO GAP Action Areas. Human-subject studies cited had independent ethics approval and informed consent; no new data were collected for this review. Results: IFAD activities led to substantial progress in dementia care services, with memory clinics, residential care facilities and daycare centres mapped, revealing regional disparities in service provision. Modifiable risk factors accounted for 39.5% of dementia cases in Italy, with an estimated 67 000 cases preventable through risk reduction. National guidelines were developed to standardise dementia care pathways, and training programmes addressed gaps in HP and caregiver preparedness, particularly highlighted by the COVID-19 pandemic. Discussion: Italy's experience provides valuable lessons for countries facing similar demographic challenges. The IFAD extension to 2024-2026 aims to address persistent regional disparities and further implement national guidelines and prevention strategies. By integrating Italy's progress with broader international frameworks, the Italian model can inform global efforts to enhance dementia care, highlighting the importance of scalable, regionally adapted strategies for addressing the growing global burden of dementia.

Indexed as

EpidemiologyMental HealthPublic Health

Identifiers

PMID40832647
PMCPMC12359490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.